286 related articles for article (PubMed ID: 28830262)
1. Nanocarriers in advanced drug targeting: setting novel paradigm in cancer therapeutics.
Akhter MH; Rizwanullah M; Ahmad J; Ahsan MJ; Mujtaba MA; Amin S
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):873-884. PubMed ID: 28830262
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions.
Raj R; Mongia P; Kumar Sahu S; Ram A
Curr Drug Targets; 2016; 17(2):206-28. PubMed ID: 26201484
[TBL] [Abstract][Full Text] [Related]
4. Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities.
Ruman U; Fakurazi S; Masarudin MJ; Hussein MZ
Int J Nanomedicine; 2020; 15():1437-1456. PubMed ID: 32184597
[TBL] [Abstract][Full Text] [Related]
5. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.
Zhang J; Tang H; Liu Z; Chen B
Int J Nanomedicine; 2017; 12():8483-8493. PubMed ID: 29238188
[TBL] [Abstract][Full Text] [Related]
6. Emerging trends in the novel drug delivery approaches for the treatment of lung cancer.
Sharma P; Mehta M; Dhanjal DS; Kaur S; Gupta G; Singh H; Thangavelu L; Rajeshkumar S; Tambuwala M; Bakshi HA; Chellappan DK; Dua K; Satija S
Chem Biol Interact; 2019 Aug; 309():108720. PubMed ID: 31226287
[TBL] [Abstract][Full Text] [Related]
7. Ligand-Installed Nanocarriers toward Precision Therapy.
Mi P; Cabral H; Kataoka K
Adv Mater; 2020 Apr; 32(13):e1902604. PubMed ID: 31353770
[TBL] [Abstract][Full Text] [Related]
8. Engineering DNA scaffolds for delivery of anticancer therapeutics.
Sun W; Gu Z
Biomater Sci; 2015 Jul; 3(7):1018-24. PubMed ID: 26221936
[TBL] [Abstract][Full Text] [Related]
9. Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications.
Chakraborty S; Dhakshinamurthy GS; Misra SK
J Biomed Mater Res A; 2017 Oct; 105(10):2906-2928. PubMed ID: 28643475
[TBL] [Abstract][Full Text] [Related]
10. Clinical advances of nanocarrier-based cancer therapy and diagnostics.
Luque-Michel E; Imbuluzqueta E; Sebastián V; Blanco-Prieto MJ
Expert Opin Drug Deliv; 2017 Jan; 14(1):75-92. PubMed ID: 27339650
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in biocompatible nanocarriers for delivery of chemotherapeutic cargoes towards cancer therapy.
Ang CY; Tan SY; Zhao Y
Org Biomol Chem; 2014 Jul; 12(27):4776-806. PubMed ID: 24737243
[TBL] [Abstract][Full Text] [Related]
12. Nanocarriers with tunable surface properties to unblock bottlenecks in systemic drug and gene delivery.
Zou H; Wang Z; Feng M
J Control Release; 2015 Sep; 214():121-33. PubMed ID: 26208425
[TBL] [Abstract][Full Text] [Related]
13. Injectable nanomaterials for drug delivery: carriers, targeting moieties, and therapeutics.
Webster DM; Sundaram P; Byrne ME
Eur J Pharm Biopharm; 2013 May; 84(1):1-20. PubMed ID: 23313176
[TBL] [Abstract][Full Text] [Related]
14. Design of multifunctional nanocarriers for delivery of anti-cancer therapy.
Mehra NK; Jain K; Jain NK
Curr Pharm Des; 2015; 21(42):6157-64. PubMed ID: 26503145
[TBL] [Abstract][Full Text] [Related]
15. Organic nanocarriers for cancer drug delivery.
López-Dávila V; Seifalian AM; Loizidou M
Curr Opin Pharmacol; 2012 Aug; 12(4):414-9. PubMed ID: 22465543
[TBL] [Abstract][Full Text] [Related]
16. Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy.
Han Y; Li Y; Zhang P; Sun J; Li X; Sun X; Kong F
Pharm Dev Technol; 2016; 21(3):277-81. PubMed ID: 25560648
[TBL] [Abstract][Full Text] [Related]
17. Passive and active tumour targeting with nanocarriers.
Hirsjärvi S; Passirani C; Benoit JP
Curr Drug Discov Technol; 2011 Sep; 8(3):188-96. PubMed ID: 21513482
[TBL] [Abstract][Full Text] [Related]
18. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
Yu HP; Aljuffali IA; Fang JY
Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
[TBL] [Abstract][Full Text] [Related]
19. Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy.
Bhatia R; Sharma A; Narang RK; Rawal RK
Curr Mol Pharmacol; 2021; 14(3):350-366. PubMed ID: 32744982
[TBL] [Abstract][Full Text] [Related]
20. Liposomes a vesicular nanocarrier: potential advancements in cancer chemotherapy.
Kumar P; Gulbake A; Jain SK
Crit Rev Ther Drug Carrier Syst; 2012; 29(5):355-419. PubMed ID: 22876808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
